Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Art Filler Contour
- Development stage
- Unknown
- Lead developer
- FILLMED
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Subcutaneous, Intradermal
01
Overview
Art Filler Contour is a sterile, pyrogen-free, physiological, cross-linked hyaluronic acid gel of non-animal origin, containing 0.3% lidocaine hydrochloride for its anesthetic properties. Developed by Fillmed (formerly Filorga), it utilizes Tri-Hyal technology, which combines three different types of hyaluronic acid—long chains, very long chains, and free HA—to provide optimal modeling, volumizing, and smoothing effects. It is specifically indicated for restoring facial volume, contouring the face (such as the jawline and chin), and correcting deep skin depressions. The cross-linking process ensures a high-viscosity gel suitable for deep dermis or supra-periosteal injection, providing long-lasting aesthetic results.
- Brand names
- Art Filler Contour
- Other names
- Fillmed Art Filler ContourFilorga Art Filler Contour
Beyond the preview
Go deeper on Art Filler Contour.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Art Filler Contour.